The most comprehensive genotyping chip on the market with 89k markers.
Representatives from Medicinal Genomics, Eurofins BioDiagnostics, and Oregon CBD provide an overview of how the CannSNP90 chip was created and validated and how it can be applied to targeted breeding projects and research projects
Topics include:
©2024 MEDICINAL GENOMICS CORPS
Copyright all right reserved.
Signup to receive email updates on blog posts, podcasts, webinars, new products, and more!
Join us at the CannMed 24 Innovation and Investment Summit, an exclusive experience of discovery, development, and networking with innovators from around the world.